Top

Endocrine

Published in:

01-05-2021 | Mood Disorders | Original Article

Increased prevalence of subclinical hypothyroidism in female hospitalized patients with depression

Authors: Shuai Zhao, Zhilu Chen, Xumiao Wang, Zhijian Yao, Qing Lu

Published in: Endocrine | Issue 2/2021

Abstract

Backgrounds

Sex differences in depressive disorder (DD) and subclinical hypothyroidism (SCH) have been well recognized. However, few studies focus on the sex differences in DD patients with SCH. The purpose of this study is to address the sex differences in DD inpatients with SCH and further investigate the clinical characteristics and associations between DD and SCH among female and male depressed inpatients.

Methods

A total of 1787 hospitalized patients with a diagnosis of DD were recruited. Depression was assessed using the Hamilton Depression Rating Scale-17 items (HAMD), and anxiety was assessed using the Hamilton Anxiety Rating Scale. Blood test, including serum thyroid hormone levels, was measured. According to different genders, associations between DD and the presence of SCH were estimated using binary logistic regression.

Results

In the 1787 hospitalized patients with DD, the prevalence of SCH was 11.8%; the prevalence of SCH in female depressed inpatients is approximately two times that of male inpatients (14.6 vs. 7.4%, P < 0.05). Logistic regression showed that recurrent episodes and high BMI were associated with SCH in female inpatients (both P < 0.05). Spearman correlation analysis showed that thyroid stimulating hormone levels were associated with BMI (P < 0.05), total cholesterol levels (P < 0.05), and low-density lipoprotein cholesterol levels (P < 0.05) in female inpatients.

Conclusions

Our present study showed that the prevalence of SCH among female hospitalized patients with depression is approximately two times that of male inpatients. Recurrent and high-BMI female depressed inpatients are at high risk to develop SCH. More attention should be paid to the thyroid function of female inpatients with DD in future clinical work.

X. Lang, X. Hou, F. Shangguan, X.Y. Zhang, Prevalence and clinical correlates of subclinical hypothyroidism in first-episode drug-naive patients with major depressive disorder in a large sample of Chinese. J. Affect Disord. 263, 507–515 (2020). https://doi.org/10.1016/j.jad.2019.11.004CrossRefPubMed

M.D. Kim, H.J. Yang, N.R. Kang, J.H. Park, Y.E. Jung, Association between subclinical hypothyroidism and metabolic syndrome among individuals with depression. J. Affect Disord. 264, 494–497 (2020). https://doi.org/10.1016/j.jad.2019.11.080CrossRefPubMed

M.H. Samuels, Subclinical hypothyroidism and depression: is there a link? J. Clin. Endocrinol. Metab. 103(5), 2061–2064 (2018). https://doi.org/10.1210/jc.2018-00276CrossRefPubMedPubMedCentral

B.M. Cohen, B.R. Sommer, A. Vuckovic, Antidepressant-resistant depression in patients with comorbid subclinical hypothyroidism or high-normal TSH levels. Am. J. Psychiatry 175(7), 598–604 (2018). https://doi.org/10.1176/appi.ajp.2017.17080949CrossRefPubMed

S. Lee, S.S. Oh, E.C. Park, S.I. Jang, Sex differences in the association between thyroid-stimulating hormone levels and depressive symptoms among the general population with normal free T4 levels. J. Affect Disord. 249, 151–158 (2019). https://doi.org/10.1016/j.jad.2019.02.027CrossRefPubMed

A. Talaei, N. Rafee, F. Rafei, A. Chehrei, TSH cut off point based on depression in hypothyroid patients. BMC Psychiatry 17(1) (2017). https://doi.org/10.1186/s12888-017-1478-9

D.S. Cooper, B. Biondi, Subclinical thyroid disease. Lancet 379(9821), 1142–1154 (2012). https://doi.org/10.1016/s0140-6736(11)60276-6CrossRefPubMed

Y. Shen, F. Wu, Y. Zhou, Y. Ma, X. Huang, Y. Ning, X. Lang, X. Luo, X. Zhang, Association of thyroid dysfunction with suicide attempts in first-episode and drug naive patients with major depressive disorder. J. Affect Disord. 259, 180–185 (2019). https://doi.org/10.1016/j.jad.2019.08.067CrossRefPubMed

A. Labaka, O. Goni-Balentziaga, A. Lebena, J. Perez-Tejada, Biological sex differences in depression: a systematic review. Biol. Res. Nurs. 20(4), 383–392 (2018). https://doi.org/10.1177/1099800418776082CrossRefPubMed

10.

R.H. Salk, J.S. Hyde, L.Y. Abramson, Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms. Psychol. Bull. 143(8), 783–822 (2017). https://doi.org/10.1037/bul0000102CrossRefPubMedPubMedCentral

11.

S.M. Marcus, K.B. Kerber, A.J. Rush, S.R. Wisniewski, A. Nierenberg, G.K. Balasubramani, L. Ritz, S. Kornstein, E.A. Young, M.H. Trivedi, Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr. Psychiatry 49(3), 238–246 (2008). https://doi.org/10.1016/j.comppsych.2007.06.012CrossRefPubMedPubMedCentral

12.

M. Altemus, N. Sarvaiya, C. Neill Epperson, Sex differences in anxiety and depression clinical perspectives. Front. Neuroendocrinol. 35(3), 320–330 (2014). https://doi.org/10.1016/j.yfrne.2014.05.004CrossRefPubMedPubMedCentral

13.

R.P. Peeters, Subclinical hypothyroidism. N. Engl. J. Med. 376(26), 2556–2565 (2017). https://doi.org/10.1056/NEJMcp1611144CrossRefPubMed

14.

B. Biondi, A.R. Cappola, D.S. Cooper, Subclinical hypothyroidism: a review. JAMA 322(2), 153–160 (2019). https://doi.org/10.1001/jama.2019.9052CrossRefPubMed

15.

D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, G.C. Dunbar, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl 20), 22–33 (1998)PubMed

16.

American Psychiatri Association, Diagnostic Criteria from DSM-IV (American Psychiatric Association, Washington, 1994)

17.

World Medical Association, World medical association declaration of helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191–2194 (2013)CrossRef

18.

M. Hamilton, A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23(1), 56–62 (1960). https://doi.org/10.1136/jnnp.23.1.56CrossRefPubMedPubMedCentral

19.

M. Hamilton, The assessment of anxiety states by rating. Psychol. Psychother. 32, 50–55 (1959)

20.

Z. Shan, L. Chen, X. Lian, C. Liu, B. Shi, L. Shi, N. Tong, S. Wang, J. Weng, J. Zhao, X. Teng, X. Yu, Y. Lai, W. Wang, C. Li, J. Mao, Y. Li, C. Fan, W. Teng, Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid 26(8), 1125–1130 (2016). https://doi.org/10.1089/thy.2015.0613CrossRefPubMed

21.

A. Rogowicz-Frontczak, B. Falkowski, A. Grzelka-Wozniak, A. Uruska, A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, Does autoimmune hypothyroidism increase the risk of neurovascular complications in type 1 diabetes? J. Endocrinol. Investig. (2020). https://doi.org/10.1007/s40618-019-01171-x

22.

E. Fuller-Thomson, J. Saini, S. Brennenstuhl, The association between depression and thyroid disorders in a regionally representative Canadian sample. Psychol. Health Med. 17, 335–345 (2012)CrossRef

23.

L. Jain, H. A., K. Verma, H. Singh, S. Aswal, A study of correlation between depression and hypothyroidism in female patients. Psychiatry J. 16(2), 283–287 (2013)

24.

J. Hazarika, K.N. Kalita, M. Sharma, S. Saikia, P. Patangia, P. Hazarika, A.C. Sarmah, Thyroid profile in depression: a cross-sectional study from North-East India. Int. J. Res. Med. Sci. 5(3) (2017). https://doi.org/10.18203/2320-6012.ijrms20170663

25.

Y.Y. Xu, J. Liang, Y. Cao, F. Shan, Y. Liu, Q.R. Xia, High levels of Nesfatin-1 in relation to the dysfunction of the hypothalamic-pituitary-adrenal and hypothalamus-pituitary-thyroid axes in depressed patients with subclinical hypothyroidism. Neuropsychiatr. Dis. Treat. 13, 1647–1653 (2017). https://doi.org/10.2147/NDT.S138954CrossRefPubMedPubMedCentral

26.

Y. Duan, X. Wang, W. Peng, Y. Feng, W. Tang, X. Wu, X. Mao, R. Bo, W. Li, J. Chen, Y. Qin, C. Liu, C. Liu, Gender-specific associations between subclinical hypothyroidism and blood pressure in Chinese adults. Endocrine 36(3), 438–444 (2009). https://doi.org/10.1007/s12020-009-9244-5CrossRefPubMed

27.

C. Kuehner, Why is depression more common among women than among men? Lancet Psychiatry 2(4), 146–158 (2017)CrossRef

28.

P.T. Loosen, A.J. Prange Jr., Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am. J. Psychiatry 139(4), 405–416 (1982). https://doi.org/10.1176/ajp.139.4.405CrossRefPubMed

29.

F. Duval, M.C. Mokrani, A. Erb, F. Gonzalez Opera, C. Calleja, V. Paris, Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients. Psychoneuroendocrinology 85, 100–109 (2017). https://doi.org/10.1016/j.psyneuen.2017.07.488CrossRefPubMed

30.

S.D. Targum, A.C. Sullivan, S.M. Byrnes, Compensatory pituitary-thyroid mechanisms in major depressive disorder. Psychiatry Res. 6(1), 85–96 (1982). https://doi.org/10.1016/0165-1781(82)90041-5CrossRefPubMed

31.

M.R. Garcia, N.D. Ryan, H. Rabinovitch, P. Ambrosini, J.A.N. Twomey, S. Iyengar, H. Novacenko, B. Nelson, J. Puig-Antich, Thyroid stimulating hormone response to thyrotropin in prepubertal depression. J. Am. Acad. Child Adolesc. Psychiatry 30(3), 398–406 (1991). https://doi.org/10.1097/00004583-199105000-00008CrossRefPubMed

32.

N. de Souza Duarte, L.M. de Almeida Corrêa, L.R. Assunção, A.A. de Menezes, O.B. de Castro, L.F. Teixeira, Relation between depression and hormonal dysregulation. Open J. Depression 6(3), 69–78 (2017). https://doi.org/10.4236/ojd.2017.63005CrossRef

33.

B. Lisowska-Myjak, A. Puchalska, N. Halasa, M. Plazinska, A. Strawa, The association between clinical and laboratory parameters in thyroid disease and nonthyroidal illness in young women. Eur. Rev. Med. Pharmacol. Sci. 23(7), 2950–2959 (2019). https://doi.org/10.26355/eurrev_201904_17575CrossRefPubMed

34.

M. Bauer, A. Heinz, P.C. Whybrow, Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol. Psychiatry 7(2), 140–156 (2002). https://doi.org/10.1038/sj.mp.4000963CrossRefPubMed

35.

C.M. Dayan, V. Panicker, Hypothyroidism and depression. Eur. Thyroid J. 2(3), 168–179 (2013). https://doi.org/10.1159/000353777CrossRefPubMedPubMedCentral

36.

S. Koner, A. Chaudhuri, A study of correlation of perceived stress and thyroid function among females in a rural population of reproductive age group. Med. J. Dr. D.Y. Patil Vidyapeeth 13(1) (2020). https://doi.org/10.4103/mjdrdypu.mjdrdypu_219_18

37.

S. Fischer, J. Strahler, C. Markert, N. Skoluda, J.M. Doerr, M. Kappert, U.M. Nater, Effects of acute psychosocial stress on the hypothalamic-pituitary-thyroid (HPT) axis in healthy women. Psychoneuroendocrinology 110, 104438 (2019). https://doi.org/10.1016/j.psyneuen.2019.104438CrossRefPubMed

38.

R. Arrojo e Drigo, T.L. Fonseca, J.P.S. Werneck-de-Castro, A.C. Bianco, Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim. Biophys. Acta 1830(7), 3956–3964 (2013). https://doi.org/10.1016/j.bbagen.2012.08.019CrossRefPubMed

39.

E. Gałecka, M. Talarowska, A. Orzechowska, P. Górski, M. Bie nkiewicz, J. Szemraj, Association of the DIO2 gene single nucleotide polymorphisms with recurrent depressive disorder. Acta Biochim. 62(2), 297–302 (2015). https://doi.org/10.18388/abp.2015_1002CrossRef

40.

C. Luongo, C. Martin, K. Vella, A. Marsili, R. Ambrosio, M. Dentice, J.W. Harney, D. Salvatore, A.M. Zavacki, P.R. Larsen, The selective loss of the type 2 iodothyronine deiodinase in mouse thyrotrophs increases basal TSH but blunts the thyrotropin response to hypothyroidism. Endocrinology 156(2), 745–754 (2015). https://doi.org/10.1210/en.2014-1698CrossRefPubMed

41.

E. Gałecka, M. Talarowska, M. Maes, K.-P. Su, P. Górski, A. Kumor-Kisielewska, J. Szemraj, Expression levels of interferon-ɣ and type 2 deiodinase in patients diagnosed with recurrent depressive disorders. Pharmacol. Rep. 70(1), 133–138 (2018). https://doi.org/10.1016/j.pharep.2017.08.009CrossRefPubMed

42.

B.M. Bocco, J.P. Werneck-de-Castro, K.C. Oliveira, G.W. Fernandes, T.L. Fonseca, B.P. Nascimento, E.A. McAninch, E. Ricci, Z. Kvárta-Papp, C. Fekete, M.M. Bernardi, B. Gereben, A.C. Bianco, M.O. Ribeiro et al. Type 2 deiodinase disruption in astrocytes results in anxiety-Depressive-Like behavior in male mice. Endocrinology 157(9), 3682–3695 (2016).CrossRef

43.

S.J. Jung, H.T. Woo, S. Cho, K. Park, S. Jeong, Y.J. Lee, D. Kang, A. Shin, Association between body size, weight change and depression: systematic review and meta-analysis. Br. J. Psychiatry 211(1), 14–21 (2017). https://doi.org/10.1192/bjp.bp.116.186726CrossRefPubMed

44.

S.E. Sharafi, G. Garmaroudi, M. Ghafouri, S.A. Bafghi, M. Ghafouri, M.R. Tabesh, Z. Alizadeh, Prevalence of anxiety and depression in patients with overweight and obesity. Obes. Med. 17 (2020). https://doi.org/10.1016/j.obmed.2019.100169

45.

C.M. Pariante, S.L. Lightman, The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 31(9), 464–468 (2008). https://doi.org/10.1016/j.tins.2008.06.006CrossRefPubMed

46.

E. Pereira-Miranda, P.R.F. Costa, V.A.O. Queiroz, M. Pereira-Santos, M.L.P. Santana, Overweight and obesity associated with higher depression prevalence in adults: a systematic review and meta-analysis. J. Am. Coll. Nutr. 36(3), 223–233 (2017). https://doi.org/10.1080/07315724.2016.1261053CrossRefPubMed

47.

L. Schmaal, P.G. Samann et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol. Psychiatry 22(6), 900–909 (2017). https://doi.org/10.1038/mp.2016.60CrossRefPubMed

48.

P. Bjorntorp, Do stress reactions cause abdominal obesity and comorbidities? Obes. Rev. 2(2), 73–86 (2001). https://doi.org/10.1046/j.1467-789x.2001.00027.xCrossRefPubMed

Title: Increased prevalence of subclinical hypothyroidism in female hospitalized patients with depression
Authors: Shuai Zhao
Zhilu Chen
Xumiao Wang
Zhijian Yao
Qing Lu
Publication date: 01-05-2021
Publisher: Springer US
Keywords: Mood Disorders
Affective Disorder
Hypothyroidism
Published in: Endocrine / Issue 2/2021
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02490-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Backgrounds

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2021

The effect of intraoperative autofluorescence monitoring on unintentional parathyroid gland excision rates and postoperative PTH concentrations—a single-blind randomized-controlled trial

Use of medical identification jewellery in children and young adults with adrenal insufficiency in Australia

Associations of GDF-15 and GDF-15/adiponectin ratio with odds of type 2 diabetes in the Chinese population

Retrospective analysis of the ultrasound features of resected thyroid nodules

The ketogenic diet corrects metabolic hypogonadism and preserves pancreatic ß-cell function in overweight/obese men: a single-arm uncontrolled study

Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials